{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:33:36Z","timestamp":1793723616017,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41575-021-00511-8","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T09:03:02Z","timestamp":1631696582000},"page":"875-884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9040-9824","authenticated-orcid":false,"given":"M. Ines","family":"Pinto-Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn A.","family":"Silvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-7267","authenticated-orcid":false,"given":"Robert P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Therrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-2665","authenticated-orcid":false,"given":"Elena F.","family":"Verdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"511_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh, P. et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 16, 823\u2013836 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"511_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl, B., Sanders, D. S. & Green, P. H. R. Coeliac disease. Lancet 391, 70\u201381 (2018).","journal-title":"Lancet"},{"key":"511_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.14309\/ajg.0000000000000523","volume":"115","author":"JA King","year":"2020","unstructured":"King, J. A. et al. Incidence of celiac disease is increasing over time: a systematic review and meta-analysis. Am. J. Gastroenterol. 115, 507\u2013525 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jama.2020.1943","volume":"323","author":"B Lebwohl","year":"2020","unstructured":"Lebwohl, B., Green, P. H. R., S\u00f6derling, J., Roelstraete, B. & Ludvigsson, J. F. Association between celiac disease and mortality risk in a swedish population. JAMA 323, 1277\u20131285 (2020).","journal-title":"JAMA"},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ajg.2013.79","volume":"108","author":"A Rubio-Tapia","year":"2013","unstructured":"Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H. & Murray, J. A. ACG clinical guidelines: diagnosis and management of celiac disease. Am. J. Gastroenterol. 108, 656\u2013676; quiz 677 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR6","unstructured":"Geller, M. G. SSCD consensus workshop on celiac disease research \u2013 Marilyn\u2019s Message March 2020. Celiac Disease Foundation https:\/\/celiac.org\/about-the-foundation\/featured-news\/2020\/03\/marilyns-message-march-2020\/ (2020)."},{"key":"511_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01828-y","volume":"18","author":"JA Tye-Din","year":"2020","unstructured":"Tye-Din, J. A. et al. Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC Med. 18, 362 (2020).","journal-title":"BMC Med."},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00251-019-01141-w","volume":"72","author":"LM Sollid","year":"2020","unstructured":"Sollid, L. M. et al. Update 2020: nomenclature and listing of celiac disease\u2013relevant gluten epitopes recognized by CD4+ T cells. Immunogenetics 72, 85\u201388 (2020).","journal-title":"Immunogenetics"},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1073\/pnas.0306885101","volume":"101","author":"C-Y Kim","year":"2004","unstructured":"Kim, C.-Y., Quarsten, H., Bergseng, E., Khosla, C. & Sollid, L. M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl Acad. Sci. USA 101, 4175\u20134179 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"511_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.immuni.2007.05.015","volume":"27","author":"KN Henderson","year":"2007","unstructured":"Henderson, K. N. et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27, 23\u201334 (2007).","journal-title":"Immunity"},{"key":"511_CR11","doi-asserted-by":"publisher","first-page":"eaaw7756","DOI":"10.1126\/sciadv.aaw7756","volume":"5","author":"G Goel","year":"2019","unstructured":"Goel, G. et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci. Adv. 5, eaaw7756 (2019).","journal-title":"Sci. Adv."},{"key":"511_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ng.3268","volume":"47","author":"J Gutierrez-Achury","year":"2015","unstructured":"Gutierrez-Achury, J. et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat. Genet. 47, 577\u2013578 (2015).","journal-title":"Nat. Genet."},{"key":"511_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/gutjnl-2016-311713","volume":"65","author":"R Kuja-Halkola","year":"2016","unstructured":"Kuja-Halkola, R. et al. Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins. Gut 65, 1793\u20131798 (2016).","journal-title":"Gut"},{"key":"511_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00281-012-0315-y","volume":"34","author":"EV Marietta","year":"2012","unstructured":"Marietta, E. V. & Murray, J. A. Animal models to study gluten sensitivity. Semin. Immunopathol. 34, 497\u2013511 (2012).","journal-title":"Semin. Immunopathol."},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.4049\/jimmunol.0900233","volume":"182","author":"AL de Kauwe","year":"2009","unstructured":"de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-Transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182, 7440\u20137450 (2009).","journal-title":"J. Immunol."},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","volume":"578","author":"V Abadie","year":"2020","unstructured":"Abadie, V. et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature 578, 600\u2013604 (2020).","journal-title":"Nature"},{"key":"511_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09037-9","volume":"10","author":"A Caminero","year":"2019","unstructured":"Caminero, A. et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat. Commun. 10, 1198 (2019).","journal-title":"Nat. Commun."},{"key":"511_CR18","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1053\/j.gastro.2019.02.028","volume":"156","author":"A Caminero","year":"2019","unstructured":"Caminero, A. et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat products. Gastroenterology 156, 2266\u20132280 (2019).","journal-title":"Gastroenterology"},{"key":"511_CR19","doi-asserted-by":"publisher","first-page":"eaba0624","DOI":"10.1126\/scitranslmed.aba0624","volume":"12","author":"B Lamas","year":"2020","unstructured":"Lamas, B. et al. Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Sci. Transl. Med. 12, eaba0624 (2020).","journal-title":"Sci. Transl. Med."},{"key":"511_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.aah5298","volume":"356","author":"R Bouziat","year":"2017","unstructured":"Bouziat, R. et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 356, 44\u201350 (2017).","journal-title":"Science"},{"key":"511_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60521-5","volume":"10","author":"W Dieterich","year":"2020","unstructured":"Dieterich, W., Neurath, M. F. & Zopf, Y. Intestinal ex\u00a0vivo organoid culture reveals altered programmed crypt stem cells in patients with celiac disease. Sci. Rep. 10, 3535 (2020).","journal-title":"Sci. Rep."},{"key":"511_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43426-w","volume":"9","author":"R Freire","year":"2019","unstructured":"Freire, R. et al. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Sci. Rep. 9, 7029 (2019).","journal-title":"Sci. Rep."},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fnut.2019.00167","volume":"6","author":"G Serena","year":"2019","unstructured":"Serena, G. et al. Intestinal epithelium modulates macrophage response to gliadin in celiac disease. Front. Nutr. 6, 167 (2019).","journal-title":"Front. Nutr."},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2018.11.048","volume":"156","author":"M Fujii","year":"2019","unstructured":"Fujii, M., Clevers, H. & Sato, T. Modeling human digestive diseases with CRISPR\u2013Cas9-modified organoids. Gastroenterology 156, 562\u2013576 (2019).","journal-title":"Gastroenterology"},{"key":"511_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20351-5","volume":"12","author":"SK Sarvestani","year":"2021","unstructured":"Sarvestani, S. K. et al. Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat. Commun. 12, 262 (2021).","journal-title":"Nat. Commun."},{"key":"511_CR26","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.cgh.2018.12.027","volume":"17","author":"BA Blansky","year":"2019","unstructured":"Blansky, B. A. et al. Lack of follow-up of pediatric patients with celiac disease. Clin. Gastroenterol. Hepatol. 17, 2603\u20132604 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter, S. M. & Cook, M. C. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun. Rev. 11, 754\u2013765 (2012).","journal-title":"Autoimmun. Rev."},{"key":"511_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","volume":"25","author":"A Christophersen","year":"2019","unstructured":"Christophersen, A. et al. Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions. Nat. Med. 25, 734\u2013737 (2019).","journal-title":"Nat. Med."},{"key":"511_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.gastro.2020.10.040","volume":"160","author":"MM Leonard","year":"2021","unstructured":"Leonard, M. M. et al. Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial. Gastroenterology 160, 720\u2013733.e8 (2021).","journal-title":"Gastroenterology"},{"key":"511_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41590-018-0130-2","volume":"19","author":"EF Verdu","year":"2018","unstructured":"Verdu, E. F. & Danska, J. S. Common ground: shared risk factors for type 1 diabetes and celiac disease. Nat. Immunol. 19, 685\u2013695 (2018).","journal-title":"Nat. Immunol."},{"key":"511_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jama.2019.10329","volume":"322","author":"C Andr\u00e9n Aronsson","year":"2019","unstructured":"Andr\u00e9n Aronsson, C. et al. Association of gluten intake during the first 5 years of life with incidence of celiac disease autoimmunity and celiac disease among children at increased risk. JAMA 322, 514\u2013523 (2019).","journal-title":"JAMA"},{"key":"511_CR32","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1136\/gutjnl-2019-319809","volume":"69","author":"K Lindfors","year":"2020","unstructured":"Lindfors, K. et al. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut 69, 1416\u20131422 (2020).","journal-title":"Gut"},{"key":"511_CR33","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jama.2017.1462","volume":"317","author":"K Bibbins-Domingo","year":"2017","unstructured":"Bibbins-Domingo, K. et al. Screening for celiac disease: US preventive services task force recommendation statement. JAMA 317, 1252\u20131257 (2017).","journal-title":"JAMA"},{"key":"511_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/apt.14625","volume":"47","author":"IA Hujoel","year":"2018","unstructured":"Hujoel, I. A. et al. Natural history and clinical detection of undiagnosed coeliac disease in a North American community. Aliment. Pharmacol. Ther. 47, 1358\u20131366 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.14309\/ajg.0000000000000751","volume":"116","author":"MG Stahl","year":"2021","unstructured":"Stahl, M. G. et al. Mass screening for celiac disease: the autoimmunity screening for kids study. Am. J. Gastroenterol. 116, 180\u2013187 (2021).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","volume":"70","author":"S Husby","year":"2020","unstructured":"Husby, S. et al. European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J. Pediatr. Gastroenterol. Nutr. 70, 141\u2013156 (2020).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"511_CR37","doi-asserted-by":"publisher","first-page":"9370397","DOI":"10.1155\/2019\/9370397","volume":"2019","author":"P Riznik","year":"2019","unstructured":"Riznik, P. et al. The use of biopsy and \u2018no-biopsy\u2019 approach for diagnosing paediatric coeliac disease in the central european region. Gastroenterol. Res. Pract. 2019, 9370397 (2019).","journal-title":"Gastroenterol. Res. Pract."},{"key":"511_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7861\/clinmed.2020-0296","volume":"20","author":"CJ Rees","year":"2020","unstructured":"Rees, C. J. et al. Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: guidance from the British Society of Gastroenterology. Clin. Med. 20, 352\u2013358 (2020).","journal-title":"Clin. Med."},{"key":"511_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/gutjnl-2012-302196","volume":"62","author":"D Leffler","year":"2013","unstructured":"Leffler, D. et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 62, 996\u20131004 (2013).","journal-title":"Gut"},{"key":"511_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/nu12010216","volume":"12","author":"HA Penny","year":"2020","unstructured":"Penny, H. A., Baggus, E. M. R., Rej, A., Snowden, J. A. & Sanders, D. S. Non-responsive coeliac disease: a comprehensive review from the NHS england national centre for refractory coeliac disease. Nutrients 12, 216 (2020).","journal-title":"Nutrients"},{"key":"511_CR41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","volume":"154","author":"VK Sarna","year":"2018","unstructured":"Sarna, V. K. et al. HLA-DQ\u2013gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption. Gastroenterology 154, 886\u2013896.e6 (2018).","journal-title":"Gastroenterology"},{"key":"511_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cei.13578","volume":"204","author":"RP Anderson","year":"2021","unstructured":"Anderson, R. P. et al. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease. Clin. Exp. Immunol. 204, 321\u2013334 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"511_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1651-2227.1953.tb05586.x","volume":"42","author":"JH van de Kamer","year":"1953","unstructured":"van de Kamer, J. H., Weijers, H. A. & Dicke, W. K. An investigation inthe the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr. 42, 223\u2013231 (1953).","journal-title":"Acta Paediatr."},{"key":"511_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.169.1.345","volume":"169","author":"L Sollid","year":"1989","unstructured":"Sollid, L. et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer. J. Exp. Med. 169, 345\u2013350 (1989).","journal-title":"J. Exp. Med."},{"key":"511_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3, 797\u2013801 (1997).","journal-title":"Nat. Med."},{"key":"511_CR46","unstructured":"Codex Alimentarius Commission. Codex standard for foods for special dietary use for persons intolerant to gluten. CSX 118-1979 (WHO, 2008)."},{"key":"511_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/jhn.12754","volume":"33","author":"N Abu-Janb","year":"2020","unstructured":"Abu-Janb, N. & Jaana, M. Facilitators and barriers to adherence to gluten-free diet among adults with celiac disease: a systematic review. J. Hum. Nutr. Diet. 33, 786\u2013810 (2020).","journal-title":"J. Hum. Nutr. Diet."},{"key":"511_CR48","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","volume":"158","author":"JA Silvester","year":"2020","unstructured":"Silvester, J. A. et al. Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten. Gastroenterology 158, 1497\u20131499.e1 (2020).","journal-title":"Gastroenterology"},{"key":"511_CR49","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/j.1572-0241.2004.40182.x","volume":"99","author":"C O\u2019Leary","year":"2004","unstructured":"O\u2019Leary, C. et al. Celiac disease and the transition from childhood to adulthood: a 28-year follow-up. Am. J. Gastroenterol. 99, 2437\u20132441 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/apt.12621","volume":"39","author":"B Lebwohl","year":"2014","unstructured":"Lebwohl, B., Murray, J. A., Rubio-Tapia, A., Green, P. H. R. & Ludvigsson, J. F. Predictors of persistent villous atrophy in coeliac disease: a population-based study. Aliment. Pharmacol. Ther. 39, 488\u2013495 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"511_CR51","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1053\/j.gastro.2016.11.043","volume":"152","author":"RS Choung","year":"2017","unstructured":"Choung, R. S. et al. Prevalence and morbidity of undiagnosed celiac disease from a community-based study. Gastroenterology 152, 830\u2013839.e5 (2017).","journal-title":"Gastroenterology"},{"key":"511_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40273-018-0707-5","volume":"37","author":"ES Mearns","year":"2019","unstructured":"Mearns, E. S. et al. Systematic literature review of the economic burden of celiac disease. Pharmacoeconomics 37, 45\u201361 (2019).","journal-title":"Pharmacoeconomics"},{"key":"511_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","volume":"18","author":"L Kivel\u00e4","year":"2021","unstructured":"Kivel\u00e4, L. et al. Current and emerging therapies for coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 18, 181\u2013195 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"511_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan, D. et al. A randomized trial of a transglutaminase 2 inhibitor for celiac disease. N. Engl. J. Med. 385, 35\u201345 (2021).","journal-title":"N. Engl. J. Med."},{"key":"511_CR55","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1053\/j.gastro.2017.08.051","volume":"153","author":"E Clerx","year":"2017","unstructured":"Clerx, E., Kupfer, S. S. & Leffler, D. A. Disparities among gastrointestinal disorders in research funding from the national institutes of health. Gastroenterology 153, 877\u2013880 (2017).","journal-title":"Gastroenterology"},{"key":"511_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1056\/NEJMoa1313977","volume":"371","author":"E Liu","year":"2014","unstructured":"Liu, E. et al. Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42\u201349 (2014).","journal-title":"N. Engl. J. Med."},{"key":"511_CR57","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/ajg.2012.219","volume":"107","author":"A Rubio-Tapia","year":"2012","unstructured":"Rubio-Tapia, A., Ludvigsson, J. F., Brantner, T. L., Murray, J. A. & Everhart, J. E. The prevalence of celiac disease in the United States. Am. J. Gastroenterol. 107, 1538\u20131544 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR58","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3945\/ajcn.111.026708","volume":"95","author":"I Comino","year":"2012","unstructured":"Comino, I. et al. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am. J. Clin. Nutr. 95, 670\u2013677 (2012).","journal-title":"Am. J. Clin. Nutr."},{"key":"511_CR59","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/apt.16075","volume":"52","author":"JA Silvester","year":"2020","unstructured":"Silvester, J. A. et al. Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet. Aliment. Pharmacol. Ther. 52, 1469\u20131479 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"511_CR60","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1399-5448.2007.00269.x","volume":"8","author":"TEDDY Study Group","year":"2007","unstructured":"TEDDY Study Group. The environmental determinants of diabetes in the young (TEDDY) study: study design. Pediatr. Diabetes 8, 286\u2013298 (2007).","journal-title":"Pediatr. Diabetes"},{"key":"511_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","volume":"36","author":"DR Getts","year":"2015","unstructured":"Getts, D. R., Shea, L. D., Miller, S. D. & King, N. J. C. Harnessing nanoparticles for immune modulation. Trends Immunol. 36, 419\u2013427 (2015).","journal-title":"Trends Immunol."},{"key":"511_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.seminoncol.2008.07.008","volume":"35","author":"M O\u2019Leary","year":"2008","unstructured":"O\u2019Leary, M., Krailo, M., Anderson, J. R. & Reaman, G. H. Progress in childhood cancer: 50 years of research collaboration, a report from the Children\u2019s Oncology Group. Semin. Oncol. 35, 484\u2013493 (2008).","journal-title":"Semin. Oncol."},{"key":"511_CR63","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","volume":"379","author":"PALISADE Group of Clinical Investigators.","year":"2018","unstructured":"PALISADE Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N. Engl. J. Med. 379, 1991\u20132001 (2018).","journal-title":"N. Engl. J. Med."},{"key":"511_CR64","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.gtc.2018.07.013","volume":"47","author":"MD Egberg","year":"2018","unstructured":"Egberg, M. D., Kappelman, M. D. & Gulati, A. S. Improving care in pediatric inflammatory bowel disease. Gastroenterol. Clin. North. Am. 47, 909\u2013919 (2018).","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"511_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/bmjqs-2013-002363","volume":"23","author":"PJ Mogayzel","year":"2014","unstructured":"Mogayzel, P. J., Dunitz, J., Marrow, L. C. & Hazle, L. A. Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network. BMJ Qual. Saf. 23, 3\u20138 (2014).","journal-title":"BMJ Qual. Saf."},{"key":"511_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1126\/science.28.718.417","volume":"28","author":"TB Osborne","year":"1908","unstructured":"Osborne, T. B. Our present knowledge of plant proteins. Science 28, 417\u2013427 (1908).","journal-title":"Science"},{"key":"511_CR67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1017\/S0029665118002549","volume":"78","author":"A Rej","year":"2019","unstructured":"Rej, A., Aziz, I. & Sanders, D. S. Breaking bread! Proc. Nutr. Soc. 78, 118\u2013125 (2019).","journal-title":"Proc. Nutr. Soc."},{"key":"511_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/TACG.S276596","volume":"14","author":"N Asri","year":"2021","unstructured":"Asri, N., Rostami-Nejad, M., Anderson, R. P. & Rostami, K. The gluten gene: unlocking the understanding of gluten sensitivity and intolerance. Appl. Clin. Genet. 14, 37\u201350 (2021).","journal-title":"Appl. Clin. Genet."},{"key":"511_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaut.2014.10.003","volume":"56","author":"MY Hardy","year":"2015","unstructured":"Hardy, M. Y. et al. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides. J. Autoimmun. 56, 56\u201365 (2015).","journal-title":"J. Autoimmun."},{"key":"511_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1399-0039.1976.tb01031.x","volume":"7","author":"BG Solheim","year":"1976","unstructured":"Solheim, B. G. et al. HLA antigens in dermatitis herpetiformis and coeliac disease. Tissue Antigens 7, 57\u201359 (1976).","journal-title":"Tissue Antigens"},{"key":"511_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2020.575844","volume":"7","author":"M Sallese","year":"2020","unstructured":"Sallese, M., Lopetuso, L. R., Efthymakis, K. & Neri, M. Beyond the HLA genes in gluten-related disorders. Front. Nutr. 7, 1\u20137 (2020).","journal-title":"Front. Nutr."},{"key":"511_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4939-2839-2_3","volume":"1326","author":"JM Ju","year":"2015","unstructured":"Ju, J. M., Marietta, E. V. & Murray, J. A. Generating transgenic mouse models for studying celiac disease. Methods Mol. Biol. 1326, 23\u201333 (2015).","journal-title":"Methods Mol. Biol."},{"key":"511_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1084\/jem.178.1.187","volume":"178","author":"KE Lundin","year":"1993","unstructured":"Lundin, K. E. et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187\u2013196 (1993).","journal-title":"J. Exp. Med."},{"key":"511_CR74","doi-asserted-by":"publisher","first-page":"21365","DOI":"10.1074\/jbc.M115.669895","volume":"290","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Structural basis for antigen recognition by transglutaminase 2-specific autoantibodies in celiac disease. J. Biol. Chem. 290, 21365\u201321375 (2015).","journal-title":"J. Biol. Chem."},{"key":"511_CR75","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41385-018-0016-5","volume":"11","author":"T Mayassi","year":"2018","unstructured":"Mayassi, T. & Jabri, B. Human intraepithelial lymphocytes. Mucosal Immunol. 11, 1281\u20131289 (2018).","journal-title":"Mucosal Immunol."},{"key":"511_CR76","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/apt.15477","volume":"50","author":"JA Tye-Din","year":"2019","unstructured":"Tye-Din, J. A. et al. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment. Pharmacol. Ther. 50, 901\u2013910 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"511_CR77","doi-asserted-by":"publisher","first-page":"G161","DOI":"10.1152\/ajpgi.00099.2019","volume":"317","author":"A Caminero","year":"2019","unstructured":"Caminero, A. & Verdu, E. F. Celiac disease: should we care about microbes? Am. J. Physiol. - Gastrointest. Liver Physiol. 317, G161\u2013G170 (2019).","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"key":"511_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(56)91854-2","volume":"270","author":"M Shiner","year":"1956","unstructured":"Shiner, M. Duodenal biopsy. Lancet 270, 17\u201319 (1956).","journal-title":"Lancet"},{"key":"511_CR79","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10620-019-05528-3","volume":"64","author":"AB Cichewicz","year":"2019","unstructured":"Cichewicz, A. B. et al. Diagnosis and treatment patterns in celiac disease. Dig. Dis. Sci. 64, 2095\u20132106 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"511_CR80","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/adc.35.183.419","volume":"35","author":"CM Anderson","year":"1960","unstructured":"Anderson, C. M. Histological changes in the duodenal mucosa in coeliac disease: Reversibility during treatment with a wheat gluten free diet. Arch. Dis. Child. 35, 419\u2013427 (1960).","journal-title":"Arch. Dis. Child."},{"key":"511_CR81","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2017.05.015","volume":"153","author":"JA Silvester","year":"2017","unstructured":"Silvester, J. A. et al. Tests for serum transglutaminase and endomysial antibodies do not detect most patients with celiac disease and persistent villous atrophy on gluten-free diets: a meta-analysis. Gastroenterology 153, 689\u2013701.e1 (2017).","journal-title":"Gastroenterology"},{"key":"511_CR82","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","volume":"4","author":"ML L\u00e4hdeaho","year":"2019","unstructured":"L\u00e4hdeaho, M. L. et al. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. Lancet Gastroenterol. Hepatol. 4, 948\u2013959 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"511_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ygh2.380","volume":"2","author":"AJM Daveson","year":"2020","unstructured":"Daveson, A. J. M. et al. Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten-free diet. GastroHep 2, 22\u201330 (2020).","journal-title":"GastroHep"},{"key":"511_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002294","volume":"3","author":"B Mor\u00f3n","year":"2008","unstructured":"Mor\u00f3n, B. et al. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS ONE 3, e2294 (2008).","journal-title":"PLoS ONE"},{"key":"511_CR85","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s10620-012-2294-1","volume":"57","author":"Shalimar","year":"2012","unstructured":"Shalimar et al. Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial. Dig. Dis. Sci. 57, 3116\u20133125 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"511_CR86","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1400697","volume":"371","author":"E Lionetti","year":"2014","unstructured":"Lionetti, E. et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N. Engl. J. Med. 371, 1295\u20131303 (2014).","journal-title":"N. Engl. J. Med."},{"key":"511_CR87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/gastro\/gov006","volume":"3","author":"K Gottlieb","year":"2015","unstructured":"Gottlieb, K., Dawson, J., Hussain, F. & Murray, J. A. Development of drugs for celiac disease: review of endpoints for phase 2 and 3 trials. Gastroenterol. Rep. 3, 91\u2013102 (2015).","journal-title":"Gastroenterol. Rep."},{"key":"511_CR88","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.gastro.2016.07.025","volume":"151","author":"D Leffler","year":"2016","unstructured":"Leffler, D. et al. Development of celiac disease therapeutics: report of the third gastroenterology regulatory endpoints and advancement of therapeutics workshop. Gastroenterology 151, 407\u2013411 (2016).","journal-title":"Gastroenterology"},{"key":"511_CR89","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa1404172","volume":"371","author":"SL Vriezinga","year":"2014","unstructured":"Vriezinga, S. L. et al. Randomized feeding intervention in infants at high risk for celiac disease. N. Engl. J. Med. 371, 1304\u20131315 (2014).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00511-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00511-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00511-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:19:54Z","timestamp":1733959194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00511-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1038\/s41575-021-00511-8","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"4 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.L. has consulted for Takeda and Anokion. D.A.L. receives salary support from Takeda Pharmaceuticals unrelated to this manuscript. M.I.P.-S. has consulted for Takeda and Lupin unrelated to this manuscript. J.A.S. has consulted for Takeda Pharmaceuticals and received grant funding from Glutenostics, Milky Way Life Sciences, the Celiac Disease Foundation and BEYOND Celiac. E.F.V. received grant funding from Biocodex Foundation and Gilead unrelated to this manuscript. R.P.A. has served as consultant for Takeda, GSK, Anokion, Allero Therapeutics, TregTherapeutics and EVOQ Therapeutics. R.P.A. is founder and shareholder of Novoviah Pharmaceuticals and is the inventor of patents relating to the diagnosis and treatment of coeliac disease. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}